Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Commercial Officer
-
Stock Symbol
-
ITCI on Nasdaq
Mark Neumann - trading volume in the past year for Intra-Cellular Therapies, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
41K |
$5.26M |
$128.20 |
Mar 1, 2025 |
Direct |
|
|
| Restricted Stock Units |
17.5K |
$2.24M |
$128.20 |
Mar 1, 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
0 |
|
|
Aug 16, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.